Menu
Contact Us
Search
GO
Why Choose Us
Innovative Approaches
Conditions
Centers & Programs
For Families
For Physicians
News
Find a Doctor
Contact Us
Clinical Trials
Directions and Parking
News
Find a Doctor
Contact Us
Clinical Trials
Directions and Parking
Why Choose Us
Expertise
Survivorship
Global Health
Leadership
History and Milestones
Innovative Approaches
CAR T-Cell Therapy
Clinical Trials for Relapsed Cancer
Gene Therapy
Immunotherapy for Children
MIBG Therapy
Pediatric Cancer Genetic Risk Program
Precision Medicine
Conditions
Blood Disorders
Brain Tumors
Leukemia & Lymphoma
Solid Tumors
Other Conditions We Treat
Centers & Programs
Blood Disorders Center
Brain Tumor Center
Hematologic Malignancy Center
Solid Tumor Center
Stem Cell Transplant Center
For Families
Become a Patient
Insurance and Financial Information
Our Facilities
Patient & Family Advisory Council
Patient and Family Support Services
Five Things Parents Should Know
Childhood Cancer Awareness Month
Education Resources
For Physicians
Referrals and Second Opinions
Clinical Trials & Research
Research Labs
Fellowship Overview
Affiliations and Consortia
Continuing Medical Education
Newsletter Sign Up
Home
>
Share
Print
Print
Sitemap
Dana Farber Childrens Hospital
Gene Therapy
Stem Cell Transplant Center
Hematologic Malignancy Center
Rare Tumors Program
Medulloblastoma Program
Glioma Program
Node Assessment Program
Leukemia Program
Lymphoma Program
Histiocytosis Program
OBSOLETE - Bone Marrow Failure and MDS Program
Thrombosis and Anticoagulation Program
OBSOLETE - Boston Hemophilia Center
Thalassemia Program
Sickle Cell Program
Rare Anemias & Iron Disorders Program
Platelet Function Disorders Program
Pediatric Cancer Genetic Risk Program
Pediatric Advanced Care Team
Pediatric Fertility Preservation Program
Psychosocial Services
Williams honored for Outstanding Achievement by ASGCT
International Gene Therapy Trial Launched at Children's Hospital Boston
Potential gene therapy approach to sickle cell disease highlighted at ASH
The American Society of Hematology Elects New Leadership
Alex's Lemonade Stand Foundation awards $1.75 million grant to Dana-Farber Boston Children's Cancer and Blood Disorders Center
National Academy of Sciences honors Dana-Farber Boston Children's Cancer and Blood Disorders Center's Orkin
Drug shortage linked to greater risk of relapse in young Hodgkin lymphoma patients
Justin Bieber Dream Date Shines Light on Rare Pediatric Cancer
American Association for Cancer Research honors D'Andrea
Key mutations discovered for most common childhood brain cancer
Dana-Farber/Children's Hospital Cancer Center establishes training program with Egypt Cancer Network and Children's Cancer Hospital Egypt
Intensified chemotherapy shows promise for children with very high-risk form of leukemia
Chondroblastoma
Revealing new mutations in pediatric myelodysplastic syndromes
Delays in diagnosis worsen outlook for minority, uninsured pediatric retinoblastoma patients, study finds
Majority of children readmitted to hospital following transplant
Building a community around vascular anomalies research
Scientists find mutation driving pediatric brain tumors
Dana Farber Boston Children s Cancer and Blood Disorders Center launches new website
New gene therapy strategy for sickle cell disease shows early promise in humans
Adrenal Tumors
Carcinoid Tumors
Carney Triad
Multiple Endocrine Neoplasia
Neuroendocrine Tumors
Paraganglioma/Pheochromocytoma
Tumors of the Pancreas
How I Live
Boston Children’s Hospital to receive $1.5M to initiate basic work to expand gene therapy treatment of sickle cell disease into developing countries
CRISPR-Cas9 screen opens new targets for Ewing sarcoma, other childhood cancers
Current Region-Wide Initiatives
Multi-center study led by Dana-Farber/Boston Children's contributes to FDA approval of a new treatment for acute lymphoblastic leukemia
Transplants from any donor without toxicity
Scott Armstrong, MD, PhD, recognized by ISSCR for contributions to basic and translational research in hematological disorders
Dana-Farber/Boston Children's Brian D. Crompton, MD, awarded research grant by the Go4theGoal Foundation
Researchers at Dana-Farber/Boston Children's and UMass Medical School optimize gene editing for sickle cell disease and beta thalassemia
Giving Medications Safely at Home (English)
Giving Medications Safely at Home (Spanish)
Giving Medications Safely at Home (Arabic)
Children with cancer wait an average of 6.5 years longer than adults to access new targeted drugs, finds study at Dana-Farber/Boston Children’s
Lynda M. Vrooman to present findings from Dana-Farber/Boston Children’s clinical trial that led to FDA approval of novel drug for treatment of ALL in young patients
Team led by Dana-Farber/Boston Children’s Kimberly Stegmaier receives SU2C Sharp Award from Stand Up To Cancer
Katherine E. Warren, MD, joins Dana-Farber/Boston Children’s as Clinical Director for Pediatric Neuro-Oncology
Dana-Farber/Boston Children's nation’s #1 pediatric cancer program
Leonard Zon, MD, honored by the American Society of Hematology for Outstanding Mentorship
Dana-Farber/Boston Children's launches first DIPG Brain Tumor Consortium
Dana-Farber/Boston Children’s Hojun Li named a 2020 Scholar Award Recipient by the American Society of Hematology
Dana-Farber/Boston Children’s faculty named 2020 Top Doctors
CAR T-Cell Therapy
CAR T-Cell Therapy for Pediatric Leukemia
CAR T-Cell Therapy for Pediatric Lymphoma
The CAR T-Cell Therapy Team
Stuart Orkin named 2020 King Faisal Prize Laureate in Medicine
Day One Talk Videos
The Osteosarcoma Institute to fund clinical trial in recurrent osteosarcoma at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Shimamura named recipient of the 2020 Frank A. Oski Memorial Lectureship from ASPHO
Count Me In launches Osteosarcoma Project
Hass-Kogan receives funding for new DIPG-specific research project from Defeat DIPG and ChadTough
Dana-Farber/Boston Children’s receives $200,000 grant from Hyundai Hope On Wheels to support COVID-19 testing
Bauer earns Outstanding New Investigator Award from ASGCT
Massive study reveals how 'hypermutated' malignant brain tumors with many mutations escape chemotherapy and immunotherapy
2020 Harrington Prize awarded to Dr. Stuart H. Orkin
Pioneering a ‘Staple’ Approach for Treating COVID-19
Pediatric neurosurgeon Lissa Baird, MD, joins Dana-Farber/Boston Children’s
Population-based registry data identifies novel cancer patterns in families of childhood cancer patients
Dana-Farber/Boston Children's named a top pediatric cancer program
Precision Medicine
Immunotherapy for Children
Brain Tumor Survivorship
Interventional Radiology
Directions and Parking
Brain Tumor Overview
What's in a name
A new, faster route for pediatric clinical trials
“Stapled” antimicrobial peptides could combat antibiotic resistance
Stuart Orkin and Daniel Bauer receive funding for sickle cell disease research from the Doris Duke Charitable Foundation
Mexico
Disparities in Outcomes for Children with Rare Eye Cancer Suggest Unequal Access to Primary Care
Study Uses Gene Editing to Take Brakes Off Lab-based Red Blood Cell Production
Precision Medicine Infographic
Clinical Trials for Relapsed Cancer
Children with Childhood Leukemia Benefit from Prophylactic Antibiotics
Early Gene Therapy Results in Wiskott-Aldrich Syndrome Promising
Therapy Directed Against Platelets Does Not Significantly Reduce Painful Crises in Sickle Cell Disease
Studies highlight new drug targets or compounds for acute myeloid leukemia
Special holiday concert features young violinist and surgeon who removed her brain tumor
More than two-thirds of teen and young adult cancer patients facing end of life use aggressive measures
Genetic Sequencing Can Help Guide Treatment in Children with Solid Tumors
Genetic Cause Identified in Rare Pediatric Brain Tumor
In Precision Medicine, Pioneering Young Patient Teaches Veteran Doctor
Transfusional Iron Overload Evaluations
Childhood leukemia patients from high-poverty areas more likely to suffer early relapse
Study explores how high-fat diet influences colon cancer
Amazing Allison: A young 'pioneer' and the Boston doctors who saved her
Armenia
The Coalition for Pediatric Medical Research: Recommended Pediatric Priorities for the Cancer Moonshot Initiative
Making a difference: Treating sickle cell disease in Liberia
Young adult survivors of childhood cancer report
Evidence suggesting link between cancer and light therapy
Q & A: Making sense of new research on possible link between phototherapy for newborn jaundice and cancer
Brave boy donates bone marrow to sister fighting leukemia
Science commentary explores ways to pay for success in gene therapy
Genetic treatments for sickle cell
We’ve known for 50 years what causes sickle cell disease. Where’s the cure?
Dual stem-cell transplant improves outlook for children with high-risk neuroblastoma
Dana-Farber Boston Children’s remains nation’s #1 pediatric cancer program
Rotationplasty
What to Expect During MIBG Treatment
Make children’s cancer research a ‘moonshot’ priority
How drug companies use gifts and internships to reach valuable hemophilia patients
America is great at beating childhood cancer and it’s about to get better
What the cancer moonshot might mean for kids
Patriots’ Nate Solder seeks normalcy after hellish year
Childhood cancer deaths: Brain cancer overtakes leukemia as top cause
Finally, hope for a young patient with CGD
Germ Cell Tumors
Ovarian Tumors in Children and Teens
Fighting genetic disease with help of HIV virus
Research into basic workings of immune system points to way of improving therapies for cancer and chronic infection
Scientists tackle DIPG, a lethal childhood brain cancer
Testicular Tumors
Gene therapy offers hope for treatment of sickle cell anemia
Boston Children’s hires a chief scientific officer
The role of early phase clinical trials in end-of-life care for children
Intimate photos show young Guatemalan boy’s journey through cancer
Os pequenos herois que venceram o cancer
Rare Non-Hodgkin Lymphoma
Primary Mediastinal B-cell Lymphoma
Diffuse Large B-cell Lymphoma
Children with Down syndrome and acute lymphoblastic leukemia
Deaths in cancer trials remain mystery for promising therapy
Pioneering doctor reflects on gene therapy’s trajectory
Sickle cell disease: An unpredictable adversary
Applying local knowledge
Germinoma
Gene therapy trial gives Coopersville toddler second chance at life
OBSOLETE - Clinical Trials
OBSOLETE - SCID-X1 Clinical Trial
OBSOLETE - CGD Trial
OBSOLETE - Adrenoleukodystrophy
OBSOLETE - Gene Therapy FAQs
OBSOLETE - Research
OBSOLETE - Meet Our Team
Phase I Trial of Immunotherapy Opens for Children with Relapsed or Treatment-resistant Leukemia
El Salvador
Liberia
Central America
Myanmar
Discussing Child’s Cancer Prognosis More Likely to Produce Peace of Mind and Decrease Anxiety in Parents
U.S. News Names Dana-Farber Boston Children’s #1 Pediatric Cancer Program
Philippines
Ethiopia
Rwanda
Dominican Republic
Egypt
What Are the Differences Between Adult and Childhood Brain Tumors?
What Specialists Does a Child See When Diagnosed with Cancer?
What You Need to Know for Life After Childhood Cancer Treatment
Reducing the toxicity of cancer treatment
Mahra Beats Cancer and Avoids Amputation
Infographic-four-things-you-need-to-know-about-childhood-cancer
Google Hangout
Haiti
Precision medicine advances pediatric brain tumor diagnosis and treatment
In overhauling Obamacare the details matter
It’s not an even playing field
Travel dreams fulfilled for 9-year-old with terminal cancer
Stem-cell-derived cells flag possible new treatment for Diamond-Blackfan anemia
Angiosarcoma
From moving mountains to climbing mountains, Fulton native seeks to redefine ‘possible’
The Lifesaving Care Act
Martial arts instructors volunteer with kids fighting cancer
One boy’s cure raises hopes and questions about gene therapy for sickle cell disease
How a child made scientists think of cytokines as knobs instead of switches
How dogs may help fight bone cancer
Leukemia in Children
MIT Tech Review gene therapy
Care in Transition Event
Anaplastic Astrocytoma
dysembryoplastic neuroepithelial tumors DNET
Dana-Farber/Boston Children's again named a top national pediatric cancer program
Novel CRISPR-Cas9 genetic screening approach enables discovery of new drug targets to aid cancer immunotherapy
Leslie Kean, MD, PhD, joins Dana-Farber/Boston Children's Stem Cell Transplantation program
OBSOLETE - Beta-Thalassemia Gene Therapy Clinical Trial
Dana-Farber and Boston Children’s Hospital teams win Moonshot grants
Ocular Oncology Service
MATCHing precision medicine to all kids with cancer
Fishing for new leads in rare mucosal melanoma
In zebrafish, a way to find new cancer therapies, targeting tumor promoters
Solving the DIPG puzzle a single cell at a time
Probing the brain’s earliest development, with a detour into rare childhood cancers
A bold strategy to enhance CAR T-cell therapies, capable of targeting DIPG and other tough-to-treat cancers
Zeroing in on the fetal-to-adult hemoglobin switch and a new way to combat sickle cell disease
A breakthrough in our understanding of how red blood cells develop
Cancer researchers hit a bullseye with a new drug target for Ewing sarcoma
Dulling cancer therapy’s double-edged sword: A new way to block tumor recurrence
Seminar: Causes and effects of the shortage of oncology drugs
The High Price of Tanning
Optimism about Pediatric Cancer Care
Dana-Farber/Boston Children's responds to FDA approval of CAR-T cell therapy
Gene therapy halts progression of cerebral adrenoleukodystrophy in clinical trial
Two Dana-Farber/Boston Children's faculty members elected to National Academy of Medicine
OBSOLETE - Sickle Cell Disease Gene Therapy Clinical Trial
A new gene therapy transplantation technique could improve treatment of neurodegenerative disease
Bursting with gene therapies and other innovative treatments, the overall survival rate for our blood and marrow transplant patients is exceeding expectations
Dana-Farber/Boston Children’s researcher is part of a new Stand Up To Cancer campaign with Marvel Studios’ Avengers and American Airlines
Endocrine-Oncology Program
Pioneering hematologist to receive 2018 Nemmers Prize in Medical Science
Liver Tumor Treatment Team
Dana-Farber/Boston Children's again ranked among the top national pediatric cancer programs
Vietnamese boy thrives after gene therapy for Wiskott-Aldrich syndrome
The space between heartache and happiness: Two sons with adrenoleukodystrophy and a gene therapy clinical trial
New gene therapy clinical trial offers hope for sickle cell disease
Four Things on the Horizon
Gene Editing Study Reveals Possible Achilles Heel of Sickle Cell Disease
Almost One Third of Families of Children with Cancer Have Unmet Basic Needs During Treatment
Second Opinions
Gene therapy trial wrenches families as one child’s death saves another
Biden should take a note from the original moonshot: Focus on just one cancer
Finding a cure wouldn’t mean we’ve defeated cancer
Outpatient bloodstream infections costly for pediatric stem cell transplant and cancer patients
Overcoming Drew’s blood disorder, together
Research registry reveals new mutations in rare childhood blood disorders
Summer Fun for Kids with Cancer
New Diller study
Dangers of Tanning Beds
Gene therapy’s time seems to have come
Childhood Cancer Awareness Month
BCL11A-based gene therapy for sickle cell disease passes key preclinical test
Discovery offers prospect of shorter treatment and cure for chronic myelogenous leukemia
Teaming with our twin in India, to take on hemophilia
About-Us
Media Relations Policy
Television Studio
Gene Therapy Trial for Bubble Boy Syndrome
New Procedures Help Pediatric Cancer Patients With Future Fertility
Haematopoietic Stem Cell Transplants
Teenager Raises Thousands to Help Children with Vascular Anomalies
Five Things Parents of Children with Cancer Should Know
After Cancer Fertility Is Often Within Reach
The Survivorship Care Gap: After Childhood and AYA Cancers, How to Keep Survivors in Follow-Up Care
How to Help Your Child if a Classmate Has Cancer
Martin Walsh's Childhood Marked by Cancer Fight
Nasopharyngeal Carcinoma
Thyroid Carcinoma
Adrenocortical Carcinoma
Hemophagocytic Lymphohistiocytosis
Patricia Branowicki Elected to American Academy of Nursing
'Care Bundle’ Prevents Central Line-Associated Bloodstream Infections in Ambulatory Pediatric Cancer Patients(2)
'Care Bundle’ Prevents Central Line-Associated Bloodstream Infections in Ambulatory Pediatric Cancer Patients
Young Warrior Shares His Story
Dana-Farber/Boston Children’s physicians among Boston Magazine’s Top Doctors 2013
International gene therapy trial for bubble boy disease shows promising early results
Rare cause of anemia in newborns often overlooked
Less Painful Drug Delivery for Pediatric Leukemia Patients is Safe, Effective, Research Suggests
Discovery holds promise for bubble boy patients
Gene therapy keeps bubble boy disease at bay in 8 children
My Sportsman: Nebraska Fan Jack Hoffman
Bubble Boy Disease Could Have a Cure
Mom, Son Battle Cancer Together with Inspiration and Teamwork
Study: Eating Nuts in Pregnancy May Lower Child’s Allergy Risk
Kidney Tumor Program
Gisele Bundchen Visits Young Malden Girl Battling Cancer
Antipsychotic Drug Exhibits Cancer-Fighting Properties
Forbes Names Scientist One of “30 under 30” to Watch
Fertility After Treatment for Childhood Cancer
Fertility Among Survivors of Childhood Cancer
Lives Less Ordinary
Mutation Discovery May Improve Treatment for Rare Brain Tumor Type
Perseverance On and Off the High School Basketball Court
Sick Kids Need Faster Drug Testing
Long-term Survival Among Patients with Most Common Childhood Brain Tumor is High
Normal Enzyme Aids a Mutant One to Fuel Blood Cancer’s Growth
Alisha’s Strength Drives Cancer Fight
Hope Grows for Sickle Cell Disease Patients
Vermont Girl Gets Second Bone Marrow Transplant
Sick Vt. Kids Highlight Need for Bone Marrow Donors
Attleboro Police Make Room for a Middleborough Boy with Cancer
NH Boy Adopted from Ethiopia Finds Bone Marrow Match with African Siblings
Scientists Find Potential Drug Targets in Deadly Pediatric Brain Tumors
Caring for a Central Line (Spanish)
Caring for a Central Line (Arabic)
Gene Linked to Pediatric Kidney Cancer Suggests New Strategies for Kidney Regeneration
Physician Advocates for Palliative Care Bill on Beacon Hill
High School Athlete Shows Strength On-field and Off
Medical Education to Fight Global Cancer
Children with Low-grade Glioma Enjoy Long-term Survival
Nurse Lauded for Efforts with Patients
Siblings Arrive from Ethiopia to Try and Save Brother's Life
Researchers Uncover Link Between Down Syndrome and Childhood Leukemia
Billerica High Cell-out to Help Boy with Leukemia Worthy of a Standing ‘O’
OBSOLETE - Meet the Boston Hemophilila Center Team
University Rallies for Student Fighting Cancer
In Children with Cancer, Navy SEALS Find “Like-Minded” Warriors
OBSOLETE - What is Gene Therapy?
Training Community-Based Pediatricians in Palliative Care
Other Conditions We Treat
Preventing Infections in Outpatients Caring for Central Lines at Home
Study Calls for Revisiting Guidelines for Screening Childhood Cancer Survivors at Risk of Congestive Heart Failure
US News Names Dana-Farber Boston Children’s #1
Mayor Walsh Reflects on his Childhood Cancer before Audience of Cancer Survivors
Global Health Statistics
Where We Work
Who We Are
Nursing
What We Do
Psychosocial Support
Stem Cell Transplants for Metabolic Disorders of the Brain
Cancer Can’t Stop this Dorchester Teenager
In Cancer’s Aftermath, Young Adults Find Support from Each Other
A Young Cancer Patient’s Take on “The Fault in Our Stars”
Exploring Scorpion Venom’s Potential to Treat Cancer
Malignant Rhabdoid Tumor
Just 16, Karina Moreira Battles Cancer in her Own Style
Researchers say Study Underscores Importance of Newborn Screening for “Bubble Boy” Disease
Niña Batalla por Garnale al Cancer
The Gospel of Calle
Newly Discovered Gene Regulator Could Precisely Target Sickle Cell Disease
Survivors of Pediatric Brain Tumors Share a Special Bond
Pediatric Melanoma
Dr Joanne Wolfe wins American Cancer Society Pathfinder Award
Bluebird Bio Advances Experimental Drug for Genetic Brain Disorder
Using a Nasogastric Tube
Caring for a Central Line (English)
Tips for Primary Care Physicians Treating Survivors of Childhood Cancer
Questions to Ask When Your Child Finishes Cancer Treatment
What to Do if Your Child Relapses
As Pediatric Cancer Survivors, Mother and Daughter Share Unique Bond
More Children Are Developing Cancer But Fewer Are Dying
A patient and doctor team come full circle
Five Ways to Support Families Dealing with Childhood Cancer
Determined to Get Back in the Game
Cancer Diagnosis Cant Shake These First-time Parents
New Research Shows Promise for Pediatric Brain Tumor Treatment
Boston Mayor Marty Walsh Proud to be a Cancer Survivor
Acute Lymphoblastic Leukemia
Common Genetic Variations May Contribute to Treatment-related Cognitive Problems in Children with Leukemia
Stem Cell Transplant without Radiation or Chemotherapy Pre-treatment Shows Promise for Rare Bone Marrow Failure
Pediatric Neuro-Oncology Clinical Fellowship
The Bad Disease: Inside Egypt’s Children’s Cancer Hospital
Unlocking the Secrets of Pediatric Cancers can Help Doctors Treat Children and Adults
ITP Kids
Intravenous Immunoglobulin IVIG
WinRho
Steroids
6-mercaptopurine
Splenectomy for ITP
Nine-year-old with Brain Tumor gets to Finish Concert with Friends
Q&A with David Williams
Family of Infant with AML Goes Home for Christmas
Relapsed Acute Lymphoblastic Leukemia (ALL)
Working with Adult Survivors of Childhood Cancers
Pathology in Global Health
Gene Therapy for “Bubble Boy” Disease Appears to be Effective and Safe
Blood Work
A Child Saved Becomes a Teen Hunting for Cures
Parents of Late Quincy Teen Watch “Fault in Our Stars” with Her Providers
Liberia’s Response to Ebola
David G. Nathan, MD, Wins Boston Children’s Hospital Inaugural Lifetime Impact Award
Researchers Take New Approach to Stop ‘Most Wanted’ Cancer Protein
Imaging Captures How Blood Stem Cells Take Root
Cancer Care for the Developing World
Boston Hospitals Pave Way for Precision Medicine
Five Things Pediatricians Should Know About Children Who’ve Had Cancer
Palliative Care Eases the Burden of Serious Illness
The Late Effects of Childhood Cancer
Survivorship Care: David B. Perini Jr. Quality of Life Clinic
Transition Off Therapy
Your Primary Team
Promising Drug Target Identified in Medulloblastoma
Relapsed or Refractory Neuroblastoma
Guatemala
Glioma in Children
Request an Appointment
Refer a Patient
Find Doctor Details
Find Doctor Results
Clinical Trials Results
Clinical Trials Detail
Bone and Soft Tissue Tumors Program
Neuroblastoma Program
Blood Disorders Center
Liver Tumor Program
Retinoblastoma Program
MyResults
Solid Tumor Center
Brain Tumor Center
Solid Tumors
Blood Disorders
Acute Myeloid Leukemia
Burkitt lymphoma
Chronic myeloid leukemia
Hodgkin Lymphoma
Juvenile myelomonocytic leukemia
Langerhans cell histiocytosis
Anaplastic Large Cell Lymphoma
Lymphoblastic lymphoma
Non-Hodgkin lymphoma
Leukemia & Lymphoma
Brain Tumors
Atypical Teratoid Rhabdoid Tumor (ATRT)
Astrocytoma
Pilocytic Astrocytoma in Children
Choroid Plexus Tumor
Diffuse Intrinsic Pontine Glioma (DIPG)
Ependymoma
Ganglioglioma
Germ cell tumors of the brain
Glioblastoma multiforme
Low Grade Glioma
Medulloblastoma
Oligodendroglioma
Optic Nerve (Pathway) Glioma in Children
Primitive Neuroectodermal Tumors (PNET)
Tectal gliomas
Thalamic or hypothalamic astrocytoma
Craniopharyngioma
Gliomatosis cerebri
Meningioma
Pleomorphic xanthoastrocytoma
Adamantinoma
Alveolar Soft Part Sarcoma
Chondrosarcoma
Desmoid tumor
Ewing sarcoma
Fibrosarcoma
Hepatoblastoma
Hepatocellular (liver carcinoma)
Liposarcoma
Neuroblastoma
Osteoblastoma
Osteosarcoma
Peripheral nerve sheath tumor (neurofibrosarcoma)
Retinoblastoma
Rhabdomyosarcoma
Schwannoma (Neurilemoma)
Soft Tissue Sarcoma
Synovial sarcoma
Wilms Tumor
Blood Transfusions
Chemotherapy
Imaging
Genetic Testing
Radiation Therapy
Surgery
MIBG Therapy
Pathology
General Inquiries
Expertise
International Patient Services
Back to School Support
Referrals and Second Opinions
Clinical Training
Become a Patient
About Us
What is a Stem Cell Transplant
Hematologist/Oncologists
Our Brain Tumor Specialists
Insurance and Financial Information
Participating in Clinical Trials
Research and Training
Resource Centers
Clinical Trials & Research
How to Choose a Pediatric Stem Cell Transplant Center
Our Treatment Team
How to Apply
Preparing for Your First Visit
Programs
Programs
Childhood Leukemia, Lymphoma, and Histiocytosis
Continuing Medical Education
Our Facilities
Types of Solid Tumors
Sibling Program
Five Things Parents Should Know
Programs
Types of Brain Tumors
Our Facilities
Conditions We Treat
Conditions Treated
Our Fellowship Program
OBSOLETE - Parents Together
MyChildren's Patient Portal
Programs
Our eNewsletter
Meet Our Specialists
Hematologic Malignancy Clinical Trials
Patient & Family Advisory Council
Research & Innovation
Leadership
Research & Innovation
Patient and Family Support Services
Affiliations and Consortia
Brain Tumor Survivorship
What to Expect
Global Health Initiative
Our Hematologists
Finding a Donor
Childhood Cancer Awareness Month
Fellows of 2014
Consultations and Second Opinions
Fellows of 2015
Education Resources
Survivorship
Centers & Programs
Survivorship
Privacy
Fellows of 2016
Hydrops-fetalis
Consultations
History and Milestones
Pediatric Transplant Nurse Focuses on Patients’ Health – and Happiness
ITP - Immune Thrombocytopenia
Megaloblastic Anemia and Pernicious Anemia
Myelodysplastic-Syndrome
2017 Pediatric Hematology/Oncology Fellows
Platelet function disorders
Flexibility and Special Programs
Polycythemia Erythrocytosis
Fellowship Program Leadership
Red Blood Cell Disorders
World-class Childhood Cancer Care
Diversity and Inclusion
Clinical Trials for Childhood Cancer and Blood Disorders
Meet Our Fellows
Sickle Cell Disease Treatment for Children
Thrombocytopenia
Thrombosis
Second Opinions
White Blood Cell Disorders
von Willebrand Disease
MoreThanYouSee
Carlie is More Than You See
Dylan is More Than You See
Carter climbs to new heights after rotationplasty
Teaghan swims through leukemia treatment
Why Choose Us
Contact Us
Global Health Statistics
Where We Work
Who We Are
Nursing
What We Do
Psychosocial Support
Questions to Ask When Your Child Finishes Cancer Treatment
What to Do if Your Child Relapses
As Pediatric Cancer Survivors, Mother and Daughter Share Unique Bond
More Children Are Developing Cancer But Fewer Are Dying
A patient and doctor team come full circle
Boston Mayor Marty Walsh Proud to be a Cancer Survivor
Pathology in Global Health
Blood Transfusions
Chemotherapy
Imaging
Radiation Therapy
Surgery
Pathology
Pediatric Advanced Care Team
Pediatric Fertility Preservation Program
Psychosocial Services
Brain Tumor Survivorship
Interventional Radiology
Survivorship Care: David B. Perini Jr. Quality of Life Clinic
Transition Off Therapy
For Physicians
Your Primary Team
Guatemala
El Salvador
Liberia
Central America
Myanmar
Philippines
Ethiopia
Rwanda
Dominican Republic
Egypt
What You Need to Know for Life After Childhood Cancer Treatment
Reducing the toxicity of cancer treatment
Google Hangout
Haiti
Mexico
Armenia
Rotationplasty
Care in Transition Event
How I Live
Current Region-Wide Initiatives
Day One Talk Videos
Global Health Initiative
Why Choose Us
History and Milestones
Expertise
Pediatric Fertility Preservation Program
Rotationplasty
Your Primary Team
Imaging
Pathology
Surgery
Rotationplasty
Interventional Radiology
Radiation Therapy
Chemotherapy
Blood Transfusions
Psychosocial Services
Pediatric Advanced Care Team
Fertility Preservation
Survivorship
Questions to Ask When Your Child Finishes Cancer Treatment
What to Do if Your Child Relapses
As Pediatric Cancer Survivors, Mother and Daughter Share Unique Bond
More Children Are Developing Cancer But Fewer Are Dying
A patient and doctor team come full circle
Boston Mayor Marty Walsh Proud to be a Cancer Survivor
Survivorship Care: David B. Perini Jr. Quality of Life Clinic
For Physicians
What You Need to Know for Life After Childhood Cancer Treatment
Reducing the toxicity of cancer treatment
Google Hangout
Care in Transition Event
Transition Off Therapy
Google Hangout
Care in Transition Event
Survivorship Care
Questions to Ask When Your Child Finishes Cancer Treatment
What to Do if Your Child Relapses
As Pediatric Cancer Survivors, Mother and Daughter Share Unique Bond
More Children Are Developing Cancer But Fewer Are Dying
A patient and doctor team come full circle
Boston Mayor Marty Walsh Proud to be a Cancer Survivor
What You Need to Know for Life After Childhood Cancer Treatment
Reducing the toxicity of cancer treatment
Brain Tumor Survivorship
Global Health
Nursing
Psychosocial Support
Pathology in Global Health
Guatemala
El Salvador
Liberia
Central America
Myanmar
Philippines
Ethiopia
Rwanda
Dominican Republic
Egypt
Haiti
Mexico
Armenia
How I Live
Current Region-Wide Initiatives
Day One Talk Videos
What We Do
Psychosocial Support
Pathology in Global Health
Nursing
Where We Work
Guatemala
El Salvador
Liberia
Central America
Myanmar
Philippines
Ethiopia
Rwanda
Dominican Republic
Egypt
Haiti
Mexico
Armenia
Current Region-Wide Initiatives
Who We Are
GLOBE Program
Global Health Statistics
Contact Us
News
Leadership
Innovative Approaches
Innovative Approaches
Genetic Testing
Immunotherapy for Children
OBSOLETE - What is Gene Therapy?
Precision Medicine Infographic
Clinical Trials for Relapsed Cancer
In Precision Medicine, Pioneering Young Patient Teaches Veteran Doctor
What to Expect During MIBG Treatment
OBSOLETE - Clinical Trials
OBSOLETE - SCID-X1 Clinical Trial
OBSOLETE - CGD Trial
OBSOLETE - Adrenoleukodystrophy
OBSOLETE - Gene Therapy FAQs
OBSOLETE - Research
OBSOLETE - Meet Our Team
OBSOLETE - Sickle Cell Disease Gene Therapy Clinical Trial
OBSOLETE - Beta-Thalassemia Gene Therapy Clinical Trial
CAR T-Cell Therapy for Pediatric Leukemia
CAR T-Cell Therapy for Pediatric Lymphoma
The CAR T-Cell Therapy Team
CAR T-Cell Therapy
CAR T-Cell Therapy for Pediatric Leukemia
CAR T-Cell Therapy for Pediatric Lymphoma
The CAR T-Cell Therapy Team
Pediatric Leukemia Treatment
Pediatric Lymphoma Treatment
CAR T-Cell Therapy Team
Clinical Trials for Relapsed Cancer (ACCT Clinic)
Gene Therapy
OBSOLETE - What is Gene Therapy?
OBSOLETE - Clinical Trials
OBSOLETE - SCID-X1 Clinical Trial
OBSOLETE - CGD Trial
OBSOLETE - Adrenoleukodystrophy
OBSOLETE - Gene Therapy FAQs
OBSOLETE - Research
OBSOLETE - Meet Our Team
OBSOLETE - Sickle Cell Disease Gene Therapy Clinical Trial
OBSOLETE - Beta-Thalassemia Gene Therapy Clinical Trial
What is Gene Therapy?
Gene Therapy FAQs
Clinical Trials
OBSOLETE - SCID-X1 Clinical Trial
OBSOLETE - CGD Trial
OBSOLETE - Adrenoleukodystrophy
OBSOLETE - Sickle Cell Disease Gene Therapy Clinical Trial
OBSOLETE - Beta-Thalassemia Gene Therapy Clinical Trial
Immunotherapy
MIBG Therapy
What to Expect During MIBG Treatment
Pediatric Cancer Genetic Risk Program
Genetic Testing
Precision Medicine
In Precision Medicine, Pioneering Young Patient Teaches Veteran Doctor
Precision Medicine Infographic
In Precision Medicine, Pioneering Young Patient Teaches Veteran Doctor
Conditions
Atypical Teratoid Rhabdoid Tumor (ATRT)
Astrocytoma
Pilocytic Astrocytoma in Children
Choroid Plexus Tumor
Diffuse Intrinsic Pontine Glioma (DIPG)
Ependymoma
Ganglioglioma
Germ cell tumors of the brain
Glioblastoma multiforme
Low Grade Glioma
Medulloblastoma
Oligodendroglioma
Optic Nerve (Pathway) Glioma in Children
Primitive Neuroectodermal Tumors (PNET)
Tectal gliomas
Thalamic or hypothalamic astrocytoma
Craniopharyngioma
Gliomatosis cerebri
Meningioma
Pleomorphic xanthoastrocytoma
Adamantinoma
Alveolar Soft Part Sarcoma
Chondrosarcoma
Desmoid tumor
Ewing sarcoma
Fibrosarcoma
Hepatoblastoma
Hepatocellular (liver carcinoma)
Liposarcoma
Neuroblastoma
Osteoblastoma
Osteosarcoma
Peripheral nerve sheath tumor (neurofibrosarcoma)
Retinoblastoma
Rhabdomyosarcoma
Schwannoma (Neurilemoma)
Soft Tissue Sarcoma
Synovial sarcoma
Wilms Tumor
Acute Myeloid Leukemia
Burkitt lymphoma
Chronic myeloid leukemia
Hodgkin Lymphoma
Juvenile myelomonocytic leukemia
Langerhans cell histiocytosis
Anaplastic Large Cell Lymphoma
Lymphoblastic lymphoma
Non-Hodgkin lymphoma
Leukemia & Lymphoma
Chondroblastoma
Brain Tumor Overview
Pediatric Melanoma
Nasopharyngeal Carcinoma
Thyroid Carcinoma
Adrenocortical Carcinoma
Hemophagocytic Lymphohistiocytosis
ITP Kids
Intravenous Immunoglobulin IVIG
WinRho
Steroids
6-mercaptopurine
Splenectomy for ITP
Relapsed or Refractory Neuroblastoma
Glioma in Children
Germ Cell Tumors
Ovarian Tumors in Children and Teens
Testicular Tumors
Rare Non-Hodgkin Lymphoma
Primary Mediastinal B-cell Lymphoma
Diffuse Large B-cell Lymphoma
Germinoma
Angiosarcoma
Leukemia in Children
Anaplastic Astrocytoma
dysembryoplastic neuroepithelial tumors DNET
Adrenal Tumors
Carcinoid Tumors
Carney Triad
Multiple Endocrine Neoplasia
Neuroendocrine Tumors
Paraganglioma/Pheochromocytoma
Tumors of the Pancreas
Relapsed Acute Lymphoblastic Leukemia (ALL)
Other Conditions We Treat
Malignant Rhabdoid Tumor
Acute Lymphoblastic Leukemia
Hydrops-fetalis
ITP - Immune Thrombocytopenia
Megaloblastic Anemia and Pernicious Anemia
Myelodysplastic-Syndrome
Platelet function disorders
Polycythemia Erythrocytosis
Red Blood Cell Disorders
Thrombocytopenia
Thrombosis
White Blood Cell Disorders
von Willebrand Disease
Blood Disorders
ITP Kids
Intravenous Immunoglobulin IVIG
WinRho
Steroids
6-mercaptopurine
Splenectomy for ITP
Hydrops-fetalis
ITP - Immune Thrombocytopenia
Megaloblastic Anemia and Pernicious Anemia
Myelodysplastic-Syndrome
Platelet function disorders
Polycythemia Erythrocytosis
Red Blood Cell Disorders
Thrombocytopenia
Thrombosis
White Blood Cell Disorders
von Willebrand Disease
Immune Thrombocytopenia
ITP Kids
Intravenous Immunoglobulin IVIG
WinRho
Steroids
6-mercaptopurine
Splenectomy for ITP
Brain Tumors
Atypical Teratoid Rhabdoid Tumor (ATRT)
Astrocytoma
Pilocytic Astrocytoma in Children
Choroid Plexus Tumor
Diffuse Intrinsic Pontine Glioma (DIPG)
Ependymoma
Ganglioglioma
Germ cell tumors of the brain
Glioblastoma multiforme
Low Grade Glioma
Medulloblastoma
Oligodendroglioma
Optic Nerve (Pathway) Glioma in Children
Primitive Neuroectodermal Tumors (PNET)
Tectal gliomas
Thalamic or hypothalamic astrocytoma
Craniopharyngioma
Gliomatosis cerebri
Meningioma
Pleomorphic xanthoastrocytoma
Brain Tumor Overview
Glioma in Children
Germinoma
Anaplastic Astrocytoma
dysembryoplastic neuroepithelial tumors DNET
Leukemia & Lymphoma
Acute Myeloid Leukemia
Burkitt lymphoma
Chronic myeloid leukemia
Hodgkin Lymphoma
Juvenile myelomonocytic leukemia
Langerhans cell histiocytosis
Anaplastic Large Cell Lymphoma
Lymphoblastic lymphoma
Non-Hodgkin lymphoma
Hemophagocytic Lymphohistiocytosis
Relapsed Acute Lymphoblastic Leukemia (ALL)
Acute Lymphoblastic Leukemia
Rare Non-Hodgkin Lymphoma
Primary Mediastinal B-cell Lymphoma
Diffuse Large B-cell Lymphoma
Leukemia in Children
Solid Tumors
Adamantinoma
Alveolar Soft Part Sarcoma
Chondrosarcoma
Desmoid tumor
Ewing sarcoma
Fibrosarcoma
Hepatoblastoma
Hepatocellular (liver carcinoma)
Liposarcoma
Neuroblastoma
Osteoblastoma
Osteosarcoma
Peripheral nerve sheath tumor (neurofibrosarcoma)
Retinoblastoma
Rhabdomyosarcoma
Schwannoma (Neurilemoma)
Soft Tissue Sarcoma
Synovial sarcoma
Wilms Tumor
Chondroblastoma
Pediatric Melanoma
Nasopharyngeal Carcinoma
Thyroid Carcinoma
Adrenocortical Carcinoma
Malignant Rhabdoid Tumor
Relapsed or Refractory Neuroblastoma
Germ Cell Tumors
Ovarian Tumors in Children and Teens
Testicular Tumors
Angiosarcoma
Adrenal Tumors
Carcinoid Tumors
Carney Triad
Multiple Endocrine Neoplasia
Neuroendocrine Tumors
Paraganglioma/Pheochromocytoma
Tumors of the Pancreas
Centers & Programs
Bone and Soft Tissue Tumors Program
Neuroblastoma Program
Liver Tumor Program
Retinoblastoma Program
Rare Tumors Program
Medulloblastoma Program
Glioma Program
Node Assessment Program
Leukemia Program
Lymphoma Program
Histiocytosis Program
Clinical Trials
OBSOLETE - Bone Marrow Failure and MDS Program
Thrombosis and Anticoagulation Program
OBSOLETE - Boston Hemophilia Center
Thalassemia Program
Sickle Cell Program
Rare Anemias & Iron Disorders Program
Platelet Function Disorders Program
Kidney Tumor Program
OBSOLETE - Meet the Boston Hemophilila Center Team
Stem Cell Transplants for Metabolic Disorders of the Brain
New Research Shows Promise for Pediatric Brain Tumor Treatment
What Are the Differences Between Adult and Childhood Brain Tumors?
Transfusional Iron Overload Evaluations
Endocrine-Oncology Program
Liver Tumor Treatment Team
Ocular Oncology Service
What is a Stem Cell Transplant
About Us
Hematologist/Oncologists
Our Brain Tumor Specialists
Our Treatment Team
How to Choose a Pediatric Stem Cell Transplant Center
Our Facilities
Types of Solid Tumors
Childhood Leukemia, Lymphoma, and Histiocytosis
Programs
Programs
Conditions We Treat
Conditions Treated
Programs
Types of Brain Tumors
Programs
Clinical Trials
Research & Innovation
Hematologic Malignancy Clinical Trials
Meet Our Specialists
Research & Innovation
What to Expect
Brain Tumor Survivorship
Finding a Donor
Consultations and Second Opinions
Our Hematologists
Clinical Trials
Clinical Trials
Survivorship
Consultations
Pediatric Transplant Nurse Focuses on Patients’ Health – and Happiness
Blood Disorders Center
OBSOLETE - Bone Marrow Failure and MDS Program
Thrombosis and Anticoagulation Program
OBSOLETE - Boston Hemophilia Center
Thalassemia Program
Sickle Cell Program
Rare Anemias & Iron Disorders Program
Platelet Function Disorders Program
OBSOLETE - Meet the Boston Hemophilila Center Team
Transfusional Iron Overload Evaluations
Conditions Treated
Research & Innovation
Consultations
Our Hematologists
Types of Blood Disorders
Programs
OBSOLETE - Bone Marrow Failure and MDS Program
Thrombosis and Anticoagulation Program
OBSOLETE - Boston Hemophilia Center
Thalassemia Program
Sickle Cell Program
Rare Anemias & Iron Disorders Program
Platelet Function Disorders Program
OBSOLETE - Meet the Boston Hemophilila Center Team
Transfusional Iron Overload Evaluations
Clinical Trials
Clinical Trials
Research & Innovation
Brain Tumor Center
Medulloblastoma Program
Glioma Program
New Research Shows Promise for Pediatric Brain Tumor Treatment
What Are the Differences Between Adult and Childhood Brain Tumors?
Our Brain Tumor Specialists
Brain Tumor Survivorship
Consultations and Second Opinions
Consultations
Brain Tumor Specialists
Types of Brain Tumors
What Are the Differences Between Adult and Childhood Brain Tumors?
Programs
Medulloblastoma Program
Glioma Program
Clinical Trials
New Research Shows Promise for Pediatric Brain Tumor Treatment
Survivorship
Hematologic Malignancy Center
Node Assessment Program
Leukemia Program
Lymphoma Program
Histiocytosis Program
About Us
Childhood Leukemia, Lymphoma, and Histiocytosis
Hematologic Malignancy Clinical Trials
About Our Center
Hematologist/Oncologists
Conditions We Treat
Programs
Node Assessment Program
Leukemia Program
Lymphoma Program
Histiocytosis Program
Clinical Trials
Cancer Survivorship
Solid Tumor Center
Bone and Soft Tissue Tumors Program
Neuroblastoma Program
Liver Tumor Program
Retinoblastoma Program
Rare Tumors Program
Kidney Tumor Program
Endocrine-Oncology Program
Liver Tumor Treatment Team
Ocular Oncology Service
Research & Innovation
Our Treatment Team
Types of Solid Tumors
Programs
Bone and Soft Tissue Tumors Program
Endocrine-Oncology Program
Liver Tumor Treatment Team
Ocular Oncology Service
Bone & Soft Tissue Program
Liver Tumor Program
Liver Tumor Treatment Team
Neuroblastoma Program
Rare Tumors Program
Retinoblastoma Program
Kidney Tumor Program
Ocular Oncology Program
Clinical Trials
Cancer Survivorship
Stem Cell Transplant Center
Stem Cell Transplants for Metabolic Disorders of the Brain
What is a Stem Cell Transplant
How to Choose a Pediatric Stem Cell Transplant Center
Our Facilities
Meet Our Specialists
What to Expect
Finding a Donor
Clinical Trials
Survivorship
Pediatric Transplant Nurse Focuses on Patients’ Health – and Happiness
Conditions We Treat
Stem Cell Transplants for Metabolic Disorders of the Brain
For Families
Childhood Cancer Awareness Month
Caring for a Central Line (Spanish)
Caring for a Central Line (Arabic)
Five Ways to Support Families Dealing with Childhood Cancer
Determined to Get Back in the Game
Cancer Diagnosis Cant Shake These First-time Parents
What Specialists Does a Child See When Diagnosed with Cancer?
Mahra Beats Cancer and Avoids Amputation
Infographic-four-things-you-need-to-know-about-childhood-cancer
Four Things on the Horizon
Giving Medications Safely at Home (English)
Giving Medications Safely at Home (Spanish)
Giving Medications Safely at Home (Arabic)
Using a Nasogastric Tube
Caring for a Central Line (English)
Back to School Support
International Patient Services
Participating in Clinical Trials
Resource Centers
Preparing for Your First Visit
Five Things Parents Should Know
Sibling Program
OBSOLETE - Parents Together
MyChildren's Patient Portal
Patient & Family Advisory Council
Childhood Cancer Awareness Month
Become a Patient
International Patient Services
Participating in Clinical Trials
Preparing for Your First Visit
MyChildren's Patient Portal
Insurance and Financial Information
Our Facilities
Patient & Family Advisory Council
Patient and Family Support Services
Back to School Support
Resource Centers
Sibling Program
OBSOLETE - Parents Together
Education Resources
Using a Nasogastric Tube
Caring for a Central Line (English)
Caring for a Central Line (Spanish)
Caring for a Central Line (Arabic)
Giving Medications Safely at Home (English)
Giving Medications Safely at Home (Spanish)
Giving Medications Safely at Home (Arabic)
Childhood Cancer Awareness
Childhood Cancer Awareness Month
Five Ways to Support Families Dealing with Childhood Cancer
Determined to Get Back in the Game
Cancer Diagnosis Cant Shake These First-time Parents
What Specialists Does a Child See When Diagnosed with Cancer?
Mahra Beats Cancer and Avoids Amputation
Infographic-four-things-you-need-to-know-about-childhood-cancer
Four Things on the Horizon
For Physicians
Pediatric Neuro-Oncology Clinical Fellowship
Clinical Training
Research and Training
Clinical Trials & Research
How to Apply
Our eNewsletter
Fellows of 2014
Fellows of 2015
Fellows of 2016
2017 Pediatric Hematology/Oncology Fellows
Flexibility and Special Programs
Fellowship Program Leadership
Diversity and Inclusion
Meet Our Fellows
Referrals and Second Opinions
Clinical Trials & Research
Our Fellowship Program
Pediatric Neuro-Oncology Clinical Fellowship
Fellows of 2014
Fellows of 2015
Fellows of 2016
2017 Pediatric Hematology/Oncology Fellows
Fellowship Program Leadership
Meet Our Fellows
How to Apply
Clinical Training
Pediatric Neuro-Oncology Clinical Fellowship
Research and Training
Diversity and Inclusion
Flexibility and Special Programs
Program Leadership
Continuing Medical Education
Newsletter Sign Up
Affiliations and Consortia
Clinical Trials
Clinical Trials Results
Clinical Trials Detail
Clinical Trials
MyResults
Find a Doctor
Find a Doctor
Find Doctor Details
Find Doctor Results
News
News
Williams honored for Outstanding Achievement by ASGCT
International Gene Therapy Trial Launched at Children's Hospital Boston
Potential gene therapy approach to sickle cell disease highlighted at ASH
The American Society of Hematology Elects New Leadership
Alex's Lemonade Stand Foundation awards $1.75 million grant to Dana-Farber Boston Children's Cancer and Blood Disorders Center
National Academy of Sciences honors Dana-Farber Boston Children's Cancer and Blood Disorders Center's Orkin
Drug shortage linked to greater risk of relapse in young Hodgkin lymphoma patients
Justin Bieber Dream Date Shines Light on Rare Pediatric Cancer
American Association for Cancer Research honors D'Andrea
Key mutations discovered for most common childhood brain cancer
Dana-Farber/Children's Hospital Cancer Center establishes training program with Egypt Cancer Network and Children's Cancer Hospital Egypt
Intensified chemotherapy shows promise for children with very high-risk form of leukemia
What's in a name
A new, faster route for pediatric clinical trials
Childhood cancer deaths: Brain cancer overtakes leukemia as top cause
Finally, hope for a young patient with CGD
Fighting genetic disease with help of HIV virus
Research into basic workings of immune system points to way of improving therapies for cancer and chronic infection
Scientists tackle DIPG, a lethal childhood brain cancer
Gene therapy offers hope for treatment of sickle cell anemia
Boston Children’s hires a chief scientific officer
The role of early phase clinical trials in end-of-life care for children
Intimate photos show young Guatemalan boy’s journey through cancer
Os pequenos herois que venceram o cancer
Children with Down syndrome and acute lymphoblastic leukemia
Deaths in cancer trials remain mystery for promising therapy
Pioneering doctor reflects on gene therapy’s trajectory
Sickle cell disease: An unpredictable adversary
Applying local knowledge
Gene therapy trial gives Coopersville toddler second chance at life
Precision medicine advances pediatric brain tumor diagnosis and treatment
In overhauling Obamacare the details matter
It’s not an even playing field
Travel dreams fulfilled for 9-year-old with terminal cancer
Stem-cell-derived cells flag possible new treatment for Diamond-Blackfan anemia
From moving mountains to climbing mountains, Fulton native seeks to redefine ‘possible’
The Lifesaving Care Act
Martial arts instructors volunteer with kids fighting cancer
Revealing new mutations in pediatric myelodysplastic syndromes
Delays in diagnosis worsen outlook for minority, uninsured pediatric retinoblastoma patients, study finds
Majority of children readmitted to hospital following transplant
Building a community around vascular anomalies research
Scientists find mutation driving pediatric brain tumors
Dana Farber Boston Children s Cancer and Blood Disorders Center launches new website
Seminar: Causes and effects of the shortage of oncology drugs
The High Price of Tanning
Optimism about Pediatric Cancer Care
Teaming with our twin in India, to take on hemophilia
Overcoming Drew’s blood disorder, together
Research registry reveals new mutations in rare childhood blood disorders
Summer Fun for Kids with Cancer
New Diller study
Dangers of Tanning Beds
Gene therapy’s time seems to have come
About-Us
Media Relations Policy
Television Studio
Gene Therapy Trial for Bubble Boy Syndrome
One boy’s cure raises hopes and questions about gene therapy for sickle cell disease
How a child made scientists think of cytokines as knobs instead of switches
How dogs may help fight bone cancer
MIT Tech Review gene therapy
Dana-Farber/Boston Children's again named a top national pediatric cancer program
Novel CRISPR-Cas9 genetic screening approach enables discovery of new drug targets to aid cancer immunotherapy
Dana-Farber/Boston Children's responds to FDA approval of CAR-T cell therapy
Gene therapy halts progression of cerebral adrenoleukodystrophy in clinical trial
Two Dana-Farber/Boston Children's faculty members elected to National Academy of Medicine
A new gene therapy transplantation technique could improve treatment of neurodegenerative disease
Bursting with gene therapies and other innovative treatments, the overall survival rate for our blood and marrow transplant patients is exceeding expectations
Dana-Farber/Boston Children’s researcher is part of a new Stand Up To Cancer campaign with Marvel Studios’ Avengers and American Airlines
Pioneering hematologist to receive 2018 Nemmers Prize in Medical Science
Dana-Farber/Boston Children's again ranked among the top national pediatric cancer programs
New Procedures Help Pediatric Cancer Patients With Future Fertility
Haematopoietic Stem Cell Transplants
Teenager Raises Thousands to Help Children with Vascular Anomalies
Five Things Parents of Children with Cancer Should Know
After Cancer Fertility Is Often Within Reach
The Survivorship Care Gap: After Childhood and AYA Cancers, How to Keep Survivors in Follow-Up Care
How to Help Your Child if a Classmate Has Cancer
Niña Batalla por Garnale al Cancer
The Gospel of Calle
Newly Discovered Gene Regulator Could Precisely Target Sickle Cell Disease
Survivors of Pediatric Brain Tumors Share a Special Bond
Dr Joanne Wolfe wins American Cancer Society Pathfinder Award
Martin Walsh's Childhood Marked by Cancer Fight
Bluebird Bio Advances Experimental Drug for Genetic Brain Disorder
Patricia Branowicki Elected to American Academy of Nursing
'Care Bundle’ Prevents Central Line-Associated Bloodstream Infections in Ambulatory Pediatric Cancer Patients(2)
'Care Bundle’ Prevents Central Line-Associated Bloodstream Infections in Ambulatory Pediatric Cancer Patients
Young Warrior Shares His Story
Dana-Farber/Boston Children’s physicians among Boston Magazine’s Top Doctors 2013
International gene therapy trial for bubble boy disease shows promising early results
Rare cause of anemia in newborns often overlooked
Less Painful Drug Delivery for Pediatric Leukemia Patients is Safe, Effective, Research Suggests
Discovery holds promise for bubble boy patients
Vietnamese boy thrives after gene therapy for Wiskott-Aldrich syndrome
The space between heartache and happiness: Two sons with adrenoleukodystrophy and a gene therapy clinical trial
New gene therapy clinical trial offers hope for sickle cell disease
Leslie Kean, MD, PhD, joins Dana-Farber/Boston Children's Stem Cell Transplantation program
MATCHing precision medicine to all kids with cancer
Fishing for new leads in rare mucosal melanoma
In zebrafish, a way to find new cancer therapies, targeting tumor promoters
Solving the DIPG puzzle a single cell at a time
Probing the brain’s earliest development, with a detour into rare childhood cancers
A bold strategy to enhance CAR T-cell therapies, capable of targeting DIPG and other tough-to-treat cancers
Gene therapy keeps bubble boy disease at bay in 8 children
My Sportsman: Nebraska Fan Jack Hoffman
Bubble Boy Disease Could Have a Cure
Mom, Son Battle Cancer Together with Inspiration and Teamwork
Study: Eating Nuts in Pregnancy May Lower Child’s Allergy Risk
Gisele Bundchen Visits Young Malden Girl Battling Cancer
Antipsychotic Drug Exhibits Cancer-Fighting Properties
Forbes Names Scientist One of “30 under 30” to Watch
Fertility After Treatment for Childhood Cancer
Fertility Among Survivors of Childhood Cancer
Lives Less Ordinary
Mutation Discovery May Improve Treatment for Rare Brain Tumor Type
Perseverance On and Off the High School Basketball Court
Sick Kids Need Faster Drug Testing
Long-term Survival Among Patients with Most Common Childhood Brain Tumor is High
Normal Enzyme Aids a Mutant One to Fuel Blood Cancer’s Growth
Alisha’s Strength Drives Cancer Fight
Working with Adult Survivors of Childhood Cancers
Hope Grows for Sickle Cell Disease Patients
Vermont Girl Gets Second Bone Marrow Transplant
Sick Vt. Kids Highlight Need for Bone Marrow Donors
Attleboro Police Make Room for a Middleborough Boy with Cancer
Zeroing in on the fetal-to-adult hemoglobin switch and a new way to combat sickle cell disease
A breakthrough in our understanding of how red blood cells develop
Cancer researchers hit a bullseye with a new drug target for Ewing sarcoma
Dulling cancer therapy’s double-edged sword: A new way to block tumor recurrence
New gene therapy strategy for sickle cell disease shows early promise in humans
Boston Children’s Hospital to receive $1.5M to initiate basic work to expand gene therapy treatment of sickle cell disease into developing countries
CRISPR-Cas9 screen opens new targets for Ewing sarcoma, other childhood cancers
Multi-center study led by Dana-Farber/Boston Children's contributes to FDA approval of a new treatment for acute lymphoblastic leukemia
Transplants from any donor without toxicity
Scott Armstrong, MD, PhD, recognized by ISSCR for contributions to basic and translational research in hematological disorders
Dana-Farber/Boston Children's Brian D. Crompton, MD, awarded research grant by the Go4theGoal Foundation
Researchers at Dana-Farber/Boston Children's and UMass Medical School optimize gene editing for sickle cell disease and beta thalassemia
Children with cancer wait an average of 6.5 years longer than adults to access new targeted drugs, finds study at Dana-Farber/Boston Children’s
NH Boy Adopted from Ethiopia Finds Bone Marrow Match with African Siblings
Scientists Find Potential Drug Targets in Deadly Pediatric Brain Tumors
Gene Linked to Pediatric Kidney Cancer Suggests New Strategies for Kidney Regeneration
Physician Advocates for Palliative Care Bill on Beacon Hill
High School Athlete Shows Strength On-field and Off
Medical Education to Fight Global Cancer
Children with Low-grade Glioma Enjoy Long-term Survival
Nurse Lauded for Efforts with Patients
Siblings Arrive from Ethiopia to Try and Save Brother's Life
Researchers Uncover Link Between Down Syndrome and Childhood Leukemia
Billerica High Cell-out to Help Boy with Leukemia Worthy of a Standing ‘O’
University Rallies for Student Fighting Cancer
In Children with Cancer, Navy SEALS Find “Like-Minded” Warriors
Training Community-Based Pediatricians in Palliative Care
Preventing Infections in Outpatients Caring for Central Lines at Home
Study Calls for Revisiting Guidelines for Screening Childhood Cancer Survivors at Risk of Congestive Heart Failure
US News Names Dana-Farber Boston Children’s #1
Mayor Walsh Reflects on his Childhood Cancer before Audience of Cancer Survivors
Cancer Can’t Stop this Dorchester Teenager
In Cancer’s Aftermath, Young Adults Find Support from Each Other
A Young Cancer Patient’s Take on “The Fault in Our Stars”
Exploring Scorpion Venom’s Potential to Treat Cancer
Just 16, Karina Moreira Battles Cancer in her Own Style
Lynda M. Vrooman to present findings from Dana-Farber/Boston Children’s clinical trial that led to FDA approval of novel drug for treatment of ALL in young patients
Team led by Dana-Farber/Boston Children’s Kimberly Stegmaier receives SU2C Sharp Award from Stand Up To Cancer
Katherine E. Warren, MD, joins Dana-Farber/Boston Children’s as Clinical Director for Pediatric Neuro-Oncology
Dana-Farber/Boston Children's nation’s #1 pediatric cancer program
Leonard Zon, MD, honored by the American Society of Hematology for Outstanding Mentorship
“Stapled” antimicrobial peptides could combat antibiotic resistance
Stuart Orkin and Daniel Bauer receive funding for sickle cell disease research from the Doris Duke Charitable Foundation
Dana-Farber/Boston Children's launches first DIPG Brain Tumor Consortium
Dana-Farber/Boston Children’s Hojun Li named a 2020 Scholar Award Recipient by the American Society of Hematology
Dana-Farber/Boston Children’s faculty named 2020 Top Doctors
Stuart Orkin named 2020 King Faisal Prize Laureate in Medicine
Researchers say Study Underscores Importance of Newborn Screening for “Bubble Boy” Disease
Tips for Primary Care Physicians Treating Survivors of Childhood Cancer
Gene Therapy for “Bubble Boy” Disease Appears to be Effective and Safe
Blood Work
A Child Saved Becomes a Teen Hunting for Cures
Parents of Late Quincy Teen Watch “Fault in Our Stars” with Her Providers
Liberia’s Response to Ebola
David G. Nathan, MD, Wins Boston Children’s Hospital Inaugural Lifetime Impact Award
Researchers Take New Approach to Stop ‘Most Wanted’ Cancer Protein
Common Genetic Variations May Contribute to Treatment-related Cognitive Problems in Children with Leukemia
Stem Cell Transplant without Radiation or Chemotherapy Pre-treatment Shows Promise for Rare Bone Marrow Failure
The Bad Disease: Inside Egypt’s Children’s Cancer Hospital
Unlocking the Secrets of Pediatric Cancers can Help Doctors Treat Children and Adults
Nine-year-old with Brain Tumor gets to Finish Concert with Friends
Q&A with David Williams
Family of Infant with AML Goes Home for Christmas
Imaging Captures How Blood Stem Cells Take Root
Cancer Care for the Developing World
Boston Hospitals Pave Way for Precision Medicine
Five Things Pediatricians Should Know About Children Who’ve Had Cancer
Palliative Care Eases the Burden of Serious Illness
The Late Effects of Childhood Cancer
Promising Drug Target Identified in Medulloblastoma
The Osteosarcoma Institute to fund clinical trial in recurrent osteosarcoma at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Shimamura named recipient of the 2020 Frank A. Oski Memorial Lectureship from ASPHO
Count Me In launches Osteosarcoma Project
Hass-Kogan receives funding for new DIPG-specific research project from Defeat DIPG and ChadTough
Dana-Farber/Boston Children’s receives $200,000 grant from Hyundai Hope On Wheels to support COVID-19 testing
Bauer earns Outstanding New Investigator Award from ASGCT
Massive study reveals how 'hypermutated' malignant brain tumors with many mutations escape chemotherapy and immunotherapy
2020 Harrington Prize awarded to Dr. Stuart H. Orkin
Pioneering a ‘Staple’ Approach for Treating COVID-19
Pediatric neurosurgeon Lissa Baird, MD, joins Dana-Farber/Boston Children’s
Population-based registry data identifies novel cancer patterns in families of childhood cancer patients
Phase I Trial of Immunotherapy Opens for Children with Relapsed or Treatment-resistant Leukemia
Discussing Child’s Cancer Prognosis More Likely to Produce Peace of Mind and Decrease Anxiety in Parents
U.S. News Names Dana-Farber Boston Children’s #1 Pediatric Cancer Program
Gene Editing Study Reveals Possible Achilles Heel of Sickle Cell Disease
Almost One Third of Families of Children with Cancer Have Unmet Basic Needs During Treatment
Disparities in Outcomes for Children with Rare Eye Cancer Suggest Unequal Access to Primary Care
Study Uses Gene Editing to Take Brakes Off Lab-based Red Blood Cell Production
Children with Childhood Leukemia Benefit from Prophylactic Antibiotics
Early Gene Therapy Results in Wiskott-Aldrich Syndrome Promising
Therapy Directed Against Platelets Does Not Significantly Reduce Painful Crises in Sickle Cell Disease
Studies highlight new drug targets or compounds for acute myeloid leukemia
Special holiday concert features young violinist and surgeon who removed her brain tumor
More than two-thirds of teen and young adult cancer patients facing end of life use aggressive measures
Genetic Sequencing Can Help Guide Treatment in Children with Solid Tumors
Genetic Cause Identified in Rare Pediatric Brain Tumor
Childhood leukemia patients from high-poverty areas more likely to suffer early relapse
Study explores how high-fat diet influences colon cancer
Amazing Allison: A young 'pioneer' and the Boston doctors who saved her
The Coalition for Pediatric Medical Research: Recommended Pediatric Priorities for the Cancer Moonshot Initiative
Dana-Farber/Boston Children's named a top pediatric cancer program
Making a difference: Treating sickle cell disease in Liberia
Young adult survivors of childhood cancer report
Evidence suggesting link between cancer and light therapy
Q & A: Making sense of new research on possible link between phototherapy for newborn jaundice and cancer
Brave boy donates bone marrow to sister fighting leukemia
Science commentary explores ways to pay for success in gene therapy
Genetic treatments for sickle cell
We’ve known for 50 years what causes sickle cell disease. Where’s the cure?
Dual stem-cell transplant improves outlook for children with high-risk neuroblastoma
Dana-Farber Boston Children’s remains nation’s #1 pediatric cancer program
Make children’s cancer research a ‘moonshot’ priority
How drug companies use gifts and internships to reach valuable hemophilia patients
Gene therapy trial wrenches families as one child’s death saves another
Biden should take a note from the original moonshot: Focus on just one cancer
Finding a cure wouldn’t mean we’ve defeated cancer
Outpatient bloodstream infections costly for pediatric stem cell transplant and cancer patients
BCL11A-based gene therapy for sickle cell disease passes key preclinical test
Discovery offers prospect of shorter treatment and cure for chronic myelogenous leukemia
America is great at beating childhood cancer and it’s about to get better
What the cancer moonshot might mean for kids
Patriots’ Nate Solder seeks normalcy after hellish year
Dana-Farber and Boston Children’s Hospital teams win Moonshot grants
Dana-Farber and Boston Children’s Hospital teams win Moonshot grants
Teams from Dana-Farber and Boston Children’s Hospital win Moonshot grants to probe childhood cancers
Dana-Farber and Boston Children’s Hospital teams win Moonshot grants
Contact Us
Contact Us
Request an Appointment
Refer a Patient
Second Opinions
General Inquiries
Directions and Parking